Bill > A08979

This bill provides comprehensive regulations for the sale of medetomidine, a sedative used for humans and dogs, within New York State. The legislation requires any business entity selling medetomidine to verify and document the intended use of the drug, which must be for institutional, veterinary, or scientific purposes. Businesses are prohibited from selling medetomidine to individuals under 21 years old and must maintain detailed sales records, including proof of age and intended use. Companies that violate these provisions will face significant financial penalties: $3,000 for a first violation and $6,500 for subsequent violations. These civil penalties will be collected by the New York State Attorney General and deposited into the state's drug treatment and public education fund. The bill defines medetomidine as a sedative with hypnotic and analgesic effects and applies to all sales regardless of the drug's quantity. The legislation will go into effect 90 days after becoming law, aimed at preventing potential misuse of this sedative and promoting responsible distribution.

Business and Industry

https://www.nysenate.gov/legislation/bills/2025/A8979